OPKO HEALTH INC
For the period ended Dec 31, 2023. Filed Mar 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 1, 2024
OPK$1.71-1.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| For the years ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Revenues: | |||
| Revenue from services | $515,275 | $755,630 | $1,607,106 |
| Revenue from products | 167,557 | 142,845 | 141,770 |
| Revenue from transfer of intellectual property and other | 180,663 | 105,721 | 25,842 |
| Total revenues | 863,495 | 1,004,196 | 1,774,718 |
| Costs and expenses: | |||
| Cost of service revenue | 445,830 | 627,548 | 1,102,172 |
| Cost of product revenue | 99,538 | 88,429 | 91,022 |
| Selling, general and administrative | 300,559 | 372,672 | 468,857 |
| Research and development | 89,593 | 73,887 | 76,850 |
| Contingent consideration | (1,036) | (1,312) | (1,703) |
| Amortization of intangible assets | 86,032 | 87,784 | 50,278 |
| Gain on sale of assets | — | (18,559) | (31,508) |
| Total costs and expenses | 1,020,516 | 1,230,449 | 1,755,968 |
| Operating income (loss) | (157,021) | (226,253) | 18,750 |
| Other income and (expense), net: | |||
| Interest income | 3,983 | 1,981 | 28 |
| Interest expense | (13,506) | (12,056) | (18,880) |
| Fair value changes of derivative instruments, net | (781) | 649 | 846 |
| Other income (expense), net | (16,994) | (155,842) | (14,769) |
| Other expense, net | (27,298) | (165,268) | (32,775) |
| Loss before income taxes and investment losses | (184,319) | (391,521) | (14,025) |
| Income tax benefit (provision) | (4,437) | 63,499 | (15,489) |
| Net loss before investment losses | (188,756) | (328,022) | (29,514) |
| Loss from investments in investees | (107) | (383) | (629) |
| Net loss | $(188,863) | $(328,405) | $(30,143) |
| Loss per share basic and diluted: | |||
| Loss per share | $(0.25) | $(0.46) | $(0.05) |
| Weighted average number of common shares outstanding, basic and diluted | 751,765,915 | 719,060,942 | 648,077,716 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.